Oncolytic efficacy of thymidine kinase-deleted vaccinia virus strain Guang9.

about

Oncolytic efficacy of thymidine kinase-deleted vaccinia virus strain Guang9.

Item

http://www.wikidata.org/entity/Q40218171

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Oncolytic efficacy of thymidine kinase-deleted vaccinia virus strain Guang9.

@en

type

Item

label

Oncolytic efficacy of thymidine kinase-deleted vaccinia virus strain Guang9.

@en

prefLabel

Oncolytic efficacy of thymidine kinase-deleted vaccinia virus strain Guang9.

@en

P1476

Oncolytic efficacy of thymidine kinase-deleted vaccinia virus strain Guang9.

@en

P2093

Biao Huang

http://www.w3.org/2001/XMLSchema#string

Bin Zhou

http://www.w3.org/2001/XMLSchema#string

Jue Zhang

http://www.w3.org/2001/XMLSchema#string

Jun Fan

http://www.w3.org/2001/XMLSchema#string

Lili Deng

http://www.w3.org/2001/XMLSchema#string

Yi Zhang

http://www.w3.org/2001/XMLSchema#string

Yuedi Ding

http://www.w3.org/2001/XMLSchema#string

P2860

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus

Vaccinia immune globulin: current policies, preparedness, and product safety and efficacy.

Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial.

Antiviral chemotherapy facilitates control of poxvirus infections through inhibition of cellular signal transduction.

A27L protein mediates vaccinia virus interaction with cell surface heparan sulfate.

Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans.

Replication-selective virotherapy for cancer: Biological principles, risk management and future directions.

Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer.

Cidofovir in the therapy and short-term prophylaxis of poxvirus infections.

P304

40533-40543

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.17125

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28465492

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

5522336

http://www.w3.org/2001/XMLSchema#string